- Report
- August 2022
- 40 Pages
India
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 80 Pages
Africa
From €1954EUR$2,000USD£1,631GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
China
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
France
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
Germany
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
India
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
Ireland
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
Japan
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
Russia
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
United States
From €1466EUR$1,500USD£1,224GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1466EUR$1,500USD£1,224GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €1466EUR$1,500USD£1,224GBP
- Report
- March 2022
- 40 Pages
India
From €1466EUR$1,500USD£1,224GBP
- Report
- February 2022
- 100 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- February 2022
- 100 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- January 2022
- 40 Pages
India
From €1466EUR$1,500USD£1,224GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €1466EUR$1,500USD£1,224GBP
The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy.
The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more